Research Labs

Our group works on the development of the cyclotron targetry to produce novel radioisotopes to the synthesis of novel radiopharmaceuticals to the translation of these imaging agents into clinical trials.

The Civitan International Neuroimaging Laboratory (CINL), a part of UAB's Research MRI Core Facility (RMRIC), provides a core resource at UAB for state-of-the-art MRI neuroimaging experiments.

We are a multi-disciplinary laboratory using cutting edge technologies to deliver focused and efficient cancer treatment.

We specialize in antibody imaging of novel biological targets to advance diagnostic tools for personalized medicine. We invite you to explore our site to learn more about our research.

The Employing Neuroimaging for Diagnosing Dementia (EN4D2) laboratory's objective is to approach the identification of biomarkers predicting dementia or cognitive decline, caused by aging and head trauma, through a multimodality approach, utilizing clinical measures, genetics, demographic measures, biofluid measures, and MRI measures (T1-weighted, high spatial and angular resolution diffusion MRI, high temporal resolution resting-state functional MRI, and cerebral blood flow measures through pseudo-continuous arterial spin labeling MRI).

The Sorace Lab’s broad research interests include improving cancer patient care through translational advancements in cancer imaging. Specifically, the lab is investigating imaging biomarkers for early response to neoadjuvant and adjuvant cancer treatment and utilizing quantitative imaging to guide and improve drug delivery of current therapies in cancer. Dr. Sorace has expertise in multimodality, non-invasive quantitative imaging to improve detection, monitoring and therapy of cancer in both preclinical animal models and clinical cancer research.